Chondroitinase ABC (EC 4.2.2.4), prepared from Proteus vulgaris, specifically hydrolyses the galactosamine-containing glycosaminoglycans (GAG), chondroitin sulphate (CS) and dermatan sulphate (DS).I Glucosamine-containing GAGs, heparan sulphate (HS) and keratan sulphate (KS), are not degraded by this enzyme. Differential degradation by chondroitinase ABC has been used to characterise urinary GAGs in the mucopolysaccharidoses (MPSI)2 and, more recently, in renal stone disease.' When establishing techniques for urinary GAG analysis pre-and postbone marrow transplantation, we attempted to use simultaneous electrophoresis of extracted GAGs after exposure to heat inactivated or active enzyme as a means to overcome incomplete resolution between CS/KS and DS/HS in a one dimensional barium acetate system. Urinary GAGs were extracted using the Alcian Blue technique.' The total GAG concentration of the extracts was estimated by cetyl pyridinium chloride complexing.' Incubation of the extracts with chondroitinase ABC was carried out as recommended 1,2 at a final concentration of GAGs of I mg/rnl, and of enzyme of 0·15 unit/ml., in a buffered medium rO'05 mol/L Tris HCI, pH 8'0), at 37°C for 4 h. Incubations were terminated by heating at 95°C for 5 min. A portion of each extract was also subjected to the same incubation using heat-inactivated enzyme.
Simultaneous electrophoresis of GAG mixtures after incubation with active/inactive chondroitinase ABC allowed good discrimination using commercially available GAGs. This was also the case for urine extracts from a number of MPSI patients. However, we occasionally obtained urinary GAG patterns which were incompatible both with the established diagnosis and with electrophoresis in a different system in which incomplete resolution occurs between CS/ DS. In these cases GAGs co-migrating with standard, commercial CS/DS, were evident despite enzyme exposure of the extract.
Further investigation illustrates the variability of this phenomenon. Table I shows that GAGs extracted from a normal urine pool were relatively resistant to chondroitinase ABC although comprising over 90% CS. A similar situation was found in the case of one MPSI patient but not in another. In both these patients the major urinary GAG was DS. In all cases, commercial CS and DS were almost completely degraded. That the large majority of un hydrolysed GAG of the normal urine pool was CS, and ofMPSI patient A was DS, was confirmed by their electrophoretic properties and subsequent susceptibility to chondroitinase ABC at a higher enzyme concentration (1-5 units/ml.), The microheterogeneity of individual GAGs both between tissues and species is well documented. However, we believe this is the first report to show that incubation conditions commensurate with almost total hydrolysis of commercially prepared CS and DS are not always sufficient for degradation of their urinary counterparts. Lack of awareness of this difference may lead to the incorrect identification of urinary GAGs.
